Log In
Print
BCIQ
Print
Print this Print this
 

PDC31 (formerly THG113.31)

  Manage Alerts
Collapse Summary General Information
Company Theratechnologies Inc.
DescriptionInjectable formulation of prostaglandin F2-alpha receptor antagonist
Molecular Target Prostaglandin F (FP) receptor (PTGFR)
Mechanism of ActionProstaglandin F (FP) receptor antagonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationUterine contractions
Indication DetailsPrevent preterm labor
Regulatory Designation

Partner

PDC Biotech GmbH


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today